PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026Archiv der Pharmazie0 citationsOpen Access

Algal–Bacterial Interaction‐Driven Secondary Metabolites From Phaeobacter inhibens and Their Anti‐Allergic Effects on Th2 Cell Immune Response

View Full Paper
JKJisu KimSPSoo‐Jin ParkYLYeo Jin Lee

Key Points

  • The strongest anti-allergic activity was observed with sinatryptin A, effectively reducing Th2 cytokine production.
  • LC-MS/UV-guided analysis identified 10 metabolites, including roseochelins C and D, from sinapic acid-treated cultures.
  • Investigation focused on how Phaeobacter inhibens interacts with algal-derived compounds to influence immune responses.
  • Findings suggest that Roseobacter-derived metabolites could be developed as novel bioactive resources for allergy treatments.

Abstract

The Roseobacter clade, a versatile Rhodobacteraceae lineage, comprises up to 20% of marine bacteria and drives key biogeochemical cycles. Phaeobacter inhibens, a representative model species, is associated with the alga Emiliania huxleyi, exhibiting a dual lifestyle that alternates between promoting symbiotic growth and displaying pathogenicity during algal senescence. In this study, we investigated the metabolic responses of P. inhibens cultured with sinapic acid, an algal-derived lignin catabolite known to modulate algal-bacterial interactions. Detailed LC-MS/UV-guided analysis of the sinapic acid-treated culture identified 10 metabolites, including two new compounds, roseochelins C (1) and D (2). All isolated compounds were tested for anti-allergic effects in Th2 cell-mediated immune responses, and sinatryptin A (4) showed the strongest activity by reducing Th2 cytokine production and blocking Th2 differentiation through inhibition of the IL-4/STAT6-GATA3/IRF4 pathway. These findings expand the chemical diversity of algal-bacterial interactions, and anti-allergic assays of the isolated metabolites highlight the potential of Roseobacter-derived compounds as novel bioactive resources.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kim et al. (2026) studied this question.

synapsesocial.com/papers/69a75b3ac6e9836116a222c9https://doi.org/10.1002/ardp.70192
Ask AI
Helpful
Bookmark
Share
View Full Paper